Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine
Journal Information
Vol. 40. Issue 1.
Pages 47-48 (January 2022)
Vol. 40. Issue 1.
Pages 47-48 (January 2022)
Letter to the Editor
Full text access
Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine
Síndrome de Ramsay Hunt tras vacunación con m-RNA SARS-COV-2
Minerva Rodríguez-Martín
Corresponding author

Corresponding author.
, Patricia Corriols-Noval, Eugenia López-Simón, Carmelo Morales-Angulo
Servicio de Otorrinolaringología, Hospital Universitario Marqués de Valdecilla, Santander, Spain
This item has received
Article information
Full Text
Download PDF
Full Text
Dear Editor,

Ramsay-Hunt syndrome typically manifests with a vesicular rash on the concha and external auditory canal associated with peripheral facial paralysis. This is caused by reactivation of latent varicella-zoster virus within the geniculate ganglion, in association with factors that influence immunosuppression, including immunosenescence.

We recently assessed a female patient at our centre who exhibited symptoms consistent with Ramsay-Hunt syndrome following administration of the COVID-19 vaccine. At the time of writing, we are not aware of any other published cases of a similar nature, just herpes zoster reactivation in other locations1–3 and Bell's palsy4,5, which is why we wanted to warn of this possibility. Our patient is a 78-year-old woman with a history of childhood poliomyelitis with sequelae in the lower limbs, as well as untreated arterial hypertension. Three days after receiving the BNT162b2 vaccine (Pfizer-BioNTech), she began to experience instability, general malaise, nausea and severe pain in the external auditory canal and right half of the cranium. She attended A&E where she underwent a range of tests, including blood tests, a PCR test for SARS-CoV-2 and a brain CT scan. She was initially diagnosed with flu-like symptoms in the context of vaccination. However, she returned to A&E two days later due to a worsening of her symptoms and decreased right-sided facial motility. Examination revealed vesicles and crusted lesions on the concha of the right ear and House-Brackmann grade IV right peripheral facial paralysis, a left horizontal-rotatory nystagmus and gait instability falling to the right side. Audiometry revealed bilateral sensorineural hearing loss that was more pronounced in the right ear (the findings in the left ear were consistent with presbycusis). Video Head Impulse Test (V-HIT) identified vestibular hypofunction of the right ear (gain of 0.43). Two weeks later, the patient's instability and sensorineural hearing loss, particularly in the right ear, persisted, accompanied by a very slight improvement in facial paralysis.

Varicella-zoster virus reactivation and idiopathic facial paralysis have often been reported in association with several virus vaccinations, including influenza and hepatitis B. It is therefore not particularly surprising that cases of both conditions in relation to SARS-CoV-2 vaccination have recently been published, as mentioned above. Evidence of peripheral facial paralysis has even emerged from a phase III clinical trial with COVID-19 vaccines4. That article reported that 844 (0.6%) of the 133,883 cases of adverse reactions to mRNA COVID-19 vaccines received by the World Health Organization pharmacovigilance database by the beginning of March (considering that more than 320 million people had been vaccinated) were facial paralysis events (749 cases were with the Pfizer-BioNTech vaccine and 95 with the Moderna vaccine). Moreover, it is important to note that 0.5% of the 1,265,182 cases reported as adverse drug reactions with other virus vaccines, and 0.7% of the 314,980 cases reported with flu vaccines, were facial paralysis events6,7. Pharmaco-epidemiological studies have been unable to demonstrate a greater risk of facial paralysis following administration of these vaccines, and the data after mRNA COVID-19 vaccine administration seems to be consistent with this.

We are not aware of any other reported cases of Ramsay-Hunt syndrome following COVID-19 vaccination or any other virus vaccination in the recent literature. This is probably because herpes zoster oticus accounts for less than 1% of all cases of herpes zoster and 12% of peripheral facial paralysis cases8, whose possible associations with vaccines are already rare. Nevertheless, it should not be forgotten that herpes zoster oticus can affect both immunocompetent as well as immunocompromised patients, even though it is much more likely in the latter group and in the elderly, as was the case with our patient. Ultimately, vaccinations with live or attenuated viruses entail immunomodulation that includes suppression of cell-mediated immunity.

To conclude this letter, we would like to emphasise the importance of vaccination to put an end to the pandemic. The possible onset of these conditions is rare and the risk is very low. However, they should still be taken into account and properly reported in order to optimise the registration of this large-scale trial that is global vaccination.

E. Eid, L. Abdullah, M. Kurban, O. Abbas.
Herpes Zoster emergence following mRNA COVID-19 vaccine.
J Med Virol., 93 (2021), pp. 5231-5232
E. Bostan, B. Yalici-Armagan.
Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence?.
J Cosmet Dermatol., 20 (2021), pp. 1566-1567
P. Rodríguez-Jiménez, P. Chicharro, L. Martos-Cabrera, M. Seguí, ÁM. Caballero, M. Llamas-Velasco, et al.
Varicella-zoster virus reactivation after SARS-Cov2 BNT162b2 mRNA vaccination: report of five cases.
JAAD Case Rep., 12 (2021), pp. 58-59
L. Renoud, C. Khouri, B. Revol, M. Lepelley, J. Perez, M. Roustit, et al.
Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization Pharmacovigilance Database.
A. Shemer, E. Pras, I. Hecht.
Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination.
Isr Med Assoc J., 23 (2021), pp. 143-144
A. Kamath, N. Maity, M.A. Nayak.
Facial paralysis following influenza vaccination: a disproportionality analysis using the Vaccine Adverse Event Reporting System Database.
Clin Drug Investig., 40 (2020), pp. 883-889
A. Rowhani-Rahbar, N.P. Klein, N. Lewis, B. Fireman, P. Ray, B. Rasgon, et al.
Immunization and Bell’s palsy in children: a case-centered analysis.
Am J Epidemiol., 175 (2012), pp. 878-885
A.E. Crouch, C. Andaloro.
Ramsay Hunt syndrome. [Updated 2020 Sep 27].
StatPearls [Internet], StatPearls Publishing, (2021),

Please cite this article as: Rodríguez-Martín M, Corriols-Noval P, López-Simón E, Morales-Angulo C. Síndrome de Ramsay Hunt tras vacunación con m-RNA SARS-COV-2. Enferm Infecc Microbiol Clin. 2022;40:47–48.

Copyright © 2021. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
No mostrar más